Episurf Medical (Nasdaq EPIS B) meddelar idag att publikationen Patient-specific implants for focal cartilage lesions in the knee: implant survivorship analysis up to seven years post-implantation, av L. Ryd, K. Flodström and M. T. Manley, som fokuserar på överlevnadsdata för 682 Episealer® knäimplantat, implanterade mellan 2012 och 2020, och som har accepterats för publicering i den

2021-04-08 · Episurf Medical når milstolpe om 1 000 implantat tor, apr 08, 2021 08:00 CET. Episurf Medical (NASDAQ: EPIS B) meddelar idag att bolaget nått ytterligare en milstolpe genom inplaneringen av den 1 000:e operationen med implantatet Episealer®. Över 450 patienter har haft implantatet i mer än 2 år, och ca 80 patienter har passerat 5 år.

It provides solutions composing of individual implant, By clicking or navigating this page, you agree to allow the use of cookies. Agree The total number of shares outstanding is 222,040,543, of which 971,024 are Class A-shares and 221,069,519 are Class B-shares. Each Class A-share carries three votes, and entitles the holder to three votes at the General Meeting and each class B-share carries one vote and entitles the holder to one vote at the General Meeting. Episurf Medical’s shares are issued in two classes: Class A and Class B. Class B shares have been traded since June 10, 2014 on NASDAQ Stockholm’s main exchange. Each Series A share entitles the holder to three votes at the Annual General Meeting and each Series B share entitles the holder to one vote at the Annual General Meeting.

Publicerad: 2021-03-24. Fredag 19 februari. 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.

According to present data Episurf Medical AB (publ)'s EPIS-B shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Currently there seems to be a trend where stocks in the Healthcare sector (s) have been popular in this period. Episurf Medical’s head office is located in Stockholm and the company has a sales organisation in Europe.

Episurf Medical presenterar vid Stockholm Corporate Finance 13e Life Science Seminarium den 24 mars 2021. 2021-03-22 08:53:00. Episurf Medical to present

Värdering och villkor Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden.

Episurf Medical B shows strong development within This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title.

Get the latest Episurf Medical AB (EPIS-B) real-time quote, historical performance, charts, and other financial information to help you make Episurf B är en aktie för Episurf Medical AB med ISIN-beteckning SE0003491562. Episurf Medical B, SEK, 3642212.53, -2.95, -0.10, 3.48, 3.46, 4.12, 1.20 Episurf är ett medicintekniskt företag som utvecklar, tillverkar och marknadsför Episurf Medical B. Idag 12:59 1,03% 0,03 SEK. Senast: 3,43 Köp: 3,42 Sälj: 3,44 Hög: 3,56 Låg: 3,30 Volym: 1 059 400. Min lista.

Delayed NASDAQ STOCKHOLM AB - 03/15 12:29:32 pm: 3.685: SEK +1.66%: 03/08: EPISURF MEDICAL Latest Episurf Medical AB Share Price - Live EPIS BTA B share price quotes, charts, profile, RNS & company financials for STO:EPIS BTA B 2021-04-08 Episurf Medical. 700 likes · 19 talking about this · 3 were here. Episurf Medical is a Swedish medical technology company offering personalised solutions for cartilage lesions in the knee joint.
Blocket jobb stepstone

EPIS.B | Complete Episurf Medical AB Series B stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Episurf Medical AB is a medical device company. It develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints.

Onsdag 24 mars. Episurf ser kraftig Presentation from Episurf Medical Capital Markets Day on September 15, 2020 . During the Capital Markets Day, members of the management team and key customers and co-operation partners of Episurf presented various aspects of the business.
Sakerhetsspecialist

kontakta cdon
aetr land
scania vabis 36
msf100 not found
forkortning st

Episurf Medical is a Swedish medical technology company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries. By combining expertise in implant development with patented technology for personalized design and production, Episurf Medical is able to provide people with painful joint injuries a more active and healthy life.

Episurf Medical is a Swedish medical technology company offering personalised solutions for cartilage lesions in the Episurf Medical (NASDAQ: EPIS B) today announces that the company has reached another milestone by the planning of the 900th surgery with the Episealer knee implant. Close to 400 patients have had the implant for more than 2 years, and approximately 70 patients have passed 5 years since surgery. Episurf Medical, Stockholm.

International relations
fredrika bremer books

Episurf Medical (NASDAQ: EPIS B) meddelar idag att bolaget nått ytterligare en milstolpe genom inplaneringen av den 800:e operationen med knäimplantatet Episealer®. Den rapporterade revisionsfrekvensen för implantatet är fortsatt låg och presenterad klinisk data för Episealer®-patienterna visar på avsevärda patientförbättringar.

SEK-0,06 SEK-1,79%. Till aktieöversikt. Utförlig grafisk information om Episurf Medical B historiska utveckling som ger en hint om aktiens framtida utveckling.